Glycemic and lipid responses to glucomannan in Thais with type 2 diabetes mellitus
- PMID: 18041436
Glycemic and lipid responses to glucomannan in Thais with type 2 diabetes mellitus
Abstract
Objective: To evaluate the benefits of glucomannan supplement on glycemic and lipid controls in type 2 diabetic patients.
Material and method: A single-blind, placebo-controlled, crossover trial with two treatments separated by a 2-week washout period was performed in 10 men and 10 women with type 2 diabetes mellitus. Two separated protocols of experiments were sequentially followed. Initially, purified glucomannan (1 g) or placebo was ingested 30 min before 75-g glucose load to evaluate their effects on glucose absorption and insulin secretion in oral glucose tolerance test (OGTT). Later, the glycemic and lipid changes after 4-week intervention with 3 g/day glucomannan comparing to the placebo were determined. The standard OGTT was performed before and after ending of each intervention.
Results: Glucomannan taken before performing the OGTT can lower the rise of blood glucose and insulin from 1 to 2 hour in comparison with the placebo, though a statistically significance of insulin was not achieved. Long-term glucomannan supplement significantly reduced the 120-min glucose area under the curve of OGTT. Glucomannan also decreased the rise of low-density lipoprotein cholesterol (LDL-C). Reductions of HOMA-insulin resistance index and body mass index were detected in glucomannan-treated group though the former was shown only in females. No within- and between-group differences of insulin, fructosamine, and other lipids were observed in glucomannan- nor placebo- treated groups.
Conclusion: In type 2 diabetes, pre-prandial glucomannan ingestion attenuated a rise of blood glucose without significantly affecting insulin levels. Long-term supplement of glucomannan to the regular diabetic regimen lessened post challenge glucose AUC and impeded the rise of LDL-C. Supplement of glucomannan may be beneficial to the glycemic and lipid controls in type 2 diabetes mellitus.
Similar articles
-
Immediate and long-term effects of glucomannan on total ghrelin and leptin in type 2 diabetes mellitus.Diabetes Res Clin Pract. 2009 Feb;83(2):e40-2. doi: 10.1016/j.diabres.2008.11.014. Epub 2008 Dec 23. Diabetes Res Clin Pract. 2009. PMID: 19108925 Clinical Trial.
-
Effect of plant sterols and glucomannan on lipids in individuals with and without type II diabetes.Eur J Clin Nutr. 2006 Apr;60(4):529-37. doi: 10.1038/sj.ejcn.1602347. Eur J Clin Nutr. 2006. PMID: 16391591 Clinical Trial.
-
Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.Eur J Endocrinol. 2008 Jan;158(1):35-46. doi: 10.1530/EJE-07-0500. Eur J Endocrinol. 2008. PMID: 18166815 Clinical Trial.
-
Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis.Am J Clin Nutr. 2008 Oct;88(4):1167-75. doi: 10.1093/ajcn/88.4.1167. Am J Clin Nutr. 2008. PMID: 18842808 Review.
-
Diet and exercise in type 2 diabetes mellitus.Endocrinol Metab Clin North Am. 2001 Dec;30(4):883-907. doi: 10.1016/s0889-8529(05)70220-6. Endocrinol Metab Clin North Am. 2001. PMID: 11727404 Review.
Cited by 5 articles
-
Efficacy of different fibres and flour mixes in South-Asian flatbreads for reducing post-prandial glucose responses in healthy adults.Eur J Nutr. 2017 Sep;56(6):2049-2060. doi: 10.1007/s00394-016-1242-9. Epub 2016 Jun 21. Eur J Nutr. 2017. PMID: 27324141 Free PMC article. Clinical Trial.
-
Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes.Open Heart. 2015 Oct 19;2(1):e000327. doi: 10.1136/openhrt-2015-000327. eCollection 2015. Open Heart. 2015. PMID: 26512331 Free PMC article. Review.
-
Acarbose, lente carbohydrate, and prebiotics promote metabolic health and longevity by stimulating intestinal production of GLP-1.Open Heart. 2015 Jan 29;2(1):e000205. doi: 10.1136/openhrt-2014-000205. eCollection 2015. Open Heart. 2015. PMID: 25685364 Free PMC article. Review.
-
Fiber facts: benefits and recommendations for individuals with type 2 diabetes.Curr Diab Rep. 2009 Oct;9(5):405-11. doi: 10.1007/s11892-009-0062-1. Curr Diab Rep. 2009. PMID: 19793511 Review.
-
Comparable postprandial glucose reductions with viscous fiber blend enriched biscuits in healthy subjects and patients with diabetes mellitus: acute randomized controlled clinical trial.Croat Med J. 2008 Dec;49(6):772-82. doi: 10.3325/cmj.2008.49.722. Croat Med J. 2008. PMID: 19090602 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
-
Other Literature Sources
-
Medical